Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis B virus C-gene variants

S Miska1, H Will

  • 1Heinrich-Pette-Institut für Experimentelle Virologie und Immunologie, Universität Hamburg, Federal Republic of Germany.

Archives of Virology. Supplementum
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-talk between phosphorylation and SUMOylation regulates transforming activities of an adenoviral oncoprotein.

Oncogene·2012
Same author

The RNA-binding protein La contributes to cell proliferation and CCND1 expression.

Oncogene·2010
Same author

Strong and selective inhibitors of hepatitis B virus replication among novel N4-hydroxy- and 5-methyl-beta-L-deoxycytidine analogues.

Antimicrobial agents and chemotherapy·2007
Same author

Spread of hepatitis B viruses in vitro requires extracellular progeny and may be codetermined by polarized egress.

Journal of virology·2004
Same author

A duck hepatitis B virus strain with a knockout mutation in the putative X ORF shows similar infectivity and in vivo growth characteristics to wild-type virus.

Virology·2003
Same author

Body language: the function of PML nuclear bodies in apoptosis regulation.

Cell death and differentiation·2003

Hepatitis B virus (HBV) sequence heterogeneity, particularly in the C-gene, impacts viral persistence and disease. Understanding these variations is crucial for effective antiviral treatment strategies.

Area of Science:

  • Virology
  • Molecular Biology
  • Hepatology

Background:

  • Hepatitis B virus (HBV) heterogeneity is increasingly linked to viral persistence, pathogenesis, and treatment response.
  • The HBV C-gene, encoding nucleocapsid protein (HBc) and e-antigen (HBeAg), is a well-studied genomic region.
  • Sequence variations within the HBV genome can influence viral behavior and clinical outcomes.

Purpose of the Study:

  • To review recent data on the sequence heterogeneity of the HBV C-gene.
  • To explore the implications of HBV C-gene sequence variations on viral persistence and pathogenesis.
  • To discuss the potential impact of HBV heterogeneity on antiviral therapy response.

Main Methods:

  • Literature review of recent studies on HBV C-gene sequence heterogeneity.

Related Experiment Videos

  • Analysis of data concerning the relationship between HBV C-gene variants and clinical outcomes.
  • Synthesis of information on the role of HBc and HBeAg variations in HBV infection.

    • Main Results:

    • Sequence heterogeneity within the HBV C-gene is a significant factor in HBV infection.
    • Variations in HBc and HBeAg sequences correlate with differences in viral persistence and disease progression.
    • Emerging data suggest a link between C-gene heterogeneity and patient response to antiviral treatments.

    Conclusions:

    • The heterogeneity of the Hepatitis B virus C-gene is a critical determinant of viral persistence and pathogenesis.
    • Further research into HBV sequence variations is essential for developing improved diagnostic and therapeutic strategies.
    • Understanding C-gene heterogeneity may lead to personalized antiviral therapy for Hepatitis B patients.